TARUGI, Patrizia Maria
 Distribuzione geografica
Continente #
NA - Nord America 14.750
EU - Europa 6.499
AS - Asia 5.852
SA - Sud America 795
AF - Africa 76
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 28.010
Nazione #
US - Stati Uniti d'America 14.618
GB - Regno Unito 2.410
SG - Singapore 1.992
CN - Cina 1.867
IT - Italia 1.347
HK - Hong Kong 890
SE - Svezia 728
BR - Brasile 659
DE - Germania 509
UA - Ucraina 323
RU - Federazione Russa 301
VN - Vietnam 295
FI - Finlandia 287
TR - Turchia 179
KR - Corea 168
FR - Francia 154
BG - Bulgaria 142
IN - India 107
ID - Indonesia 93
NL - Olanda 80
CA - Canada 55
JP - Giappone 51
AR - Argentina 50
BE - Belgio 49
MX - Messico 42
BD - Bangladesh 34
PK - Pakistan 30
ES - Italia 29
IE - Irlanda 28
ZA - Sudafrica 23
AT - Austria 21
IQ - Iraq 21
PL - Polonia 20
AU - Australia 19
CO - Colombia 18
EC - Ecuador 18
EU - Europa 15
IR - Iran 14
BZ - Belize 13
CH - Svizzera 13
LT - Lituania 13
VE - Venezuela 12
EG - Egitto 11
PY - Paraguay 10
SA - Arabia Saudita 10
KZ - Kazakistan 9
PE - Perù 9
TN - Tunisia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
KE - Kenya 8
MY - Malesia 8
TW - Taiwan 8
CL - Cile 7
UY - Uruguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
NP - Nepal 6
PH - Filippine 6
PT - Portogallo 6
BO - Bolivia 5
HU - Ungheria 5
JO - Giordania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
LK - Sri Lanka 4
MA - Marocco 4
TT - Trinidad e Tobago 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
KG - Kirghizistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
NE - Niger 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
GA - Gabon 1
Totale 27.992
Città #
Southend 1.766
Fairfield 1.667
Santa Clara 1.454
Singapore 1.321
Ashburn 1.178
Woodbridge 1.149
Houston 890
Hong Kong 877
Jacksonville 702
Hefei 700
Chandler 664
Seattle 637
Wilmington 615
Ann Arbor 522
Cambridge 488
Dearborn 403
Nyköping 396
London 347
Beijing 271
Modena 252
Los Angeles 224
San Jose 210
Chicago 194
Helsinki 176
Seoul 158
San Diego 151
Princeton 149
The Dalles 139
Sofia 138
New York 130
Milan 118
Eugene 110
Buffalo 102
Ho Chi Minh City 95
Moscow 95
Rome 91
Council Bluffs 90
Salt Lake City 85
Shanghai 79
Izmir 74
Jakarta 73
Columbus 68
Des Moines 67
Dallas 65
Hanoi 62
Falls Church 61
São Paulo 52
Grafing 51
Elk Grove Village 45
Munich 43
Bremen 39
Naples 36
Boardman 34
Brussels 34
Frankfurt am Main 30
Tampa 30
Redwood City 29
Atlanta 28
Nanjing 28
Rio de Janeiro 28
Tokyo 28
Dublin 25
Brooklyn 23
Detroit 23
Guangzhou 23
Kunming 23
Nuremberg 22
Bologna 21
Norwalk 21
Mexico City 20
Turin 20
San Mateo 19
Kent 18
Padova 18
Belo Horizonte 17
Kilburn 17
San Francisco 16
Verona 16
Florence 15
Montreal 15
Orem 15
Paris 15
Phoenix 15
Poplar 15
Redondo Beach 15
Reggio Emilia 15
Toronto 15
Buenos Aires 14
Dulles 14
Indiana 14
Lancaster 14
Belize City 13
Fremont 13
Hounslow 13
Jinan 13
Stockholm 13
Warsaw 13
Islington 12
Manchester 12
Miami 12
Totale 20.485
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.082
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 479
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 431
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 411
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol 373
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 335
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 333
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 312
Altered mRNA splicing in lipoprotein disorders 308
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 305
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 305
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 302
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations 298
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 283
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins. 281
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 280
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 279
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 278
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 277
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia 275
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 275
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 273
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 272
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum(PXE). 272
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 260
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 258
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 257
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 251
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects 251
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 248
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis 248
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B 247
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 247
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 246
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 244
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 241
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 241
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 238
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 238
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 237
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 237
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 235
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 233
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia 232
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 232
A 54-year-old diabetic man with low serum cholesterol. 231
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 229
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 228
Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. 227
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. 226
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 222
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 221
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 221
Pediatric gallstone disease in familial hypobetalipoproteinemia 220
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 220
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 218
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 217
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 215
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 215
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. 214
PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia 213
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 212
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. 211
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 209
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 204
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia. 204
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide 204
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 203
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 203
Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate 202
The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure 200
Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. 200
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 199
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 199
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 199
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 198
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations 198
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function 196
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 195
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia 192
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 189
Cholesterol synthesis in freshly isolated human leukocytes. 186
Synthesis and secretion of apolipoprotein A-I by chick skin. 186
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome 185
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 185
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 184
Dyslipidemia in rats with hypothyroidism 183
Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene. 183
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 179
Abetalipoproteinemia in an infant with severe clinical phenotype and a novel mutation 176
Exome Sequencing in Suspected Monogenic Dyslipidemias 172
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 172
Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. 168
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 168
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 167
Heterozygous familial hypobetalipoproteinemia associated with fatty liver 164
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 163
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia 162
Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick. 159
Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma 158
Totale 24.294
Categoria #
all - tutte 116.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.517 0 0 0 0 0 0 285 370 105 380 206 171
2021/20222.572 151 283 219 191 56 213 151 106 282 215 454 251
2022/20232.204 257 218 159 179 252 351 40 196 294 46 131 81
2023/20241.654 73 83 149 147 301 148 131 187 74 120 49 192
2024/20255.494 184 50 118 376 1.049 849 444 333 501 241 612 737
2025/20265.664 726 466 932 1.027 1.527 741 245 0 0 0 0 0
Totale 28.195